StreetInsider.com News Articles

Form 8-K WINDTREE THERAPEUTICS For: Jan 05

Wed, 07 Jan 2026 16:53:00 -0500

si-local-file:///var/storage/secattach/20260107/25820938.html

Form 8-K WINDTREE THERAPEUTICS For: Jan 05

Wed, 07 Jan 2026 16:53:00 -0500

si-local-file:///var/storage/secattach/20260107/25820938.html

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

Tue, 23 Dec 2025 09:00:00 -0500

Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues)

Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000

Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings

WARRINGTON, Pa., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

Tue, 23 Dec 2025 09:00:00 -0500

Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000

Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings

WARRINGTON, Pa., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

Tue, 23 Dec 2025 09:00:00 -0500

Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000

Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings

WARRINGTON, Pa., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

Tue, 23 Dec 2025 09:00:00 -0500

Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000

Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings

WARRINGTON, Pa., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

Tue, 23 Dec 2025 09:00:00 -0500

Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000

Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings

WARRINGTON, Pa., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

Tue, 23 Dec 2025 09:00:00 -0500

Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000

Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings

WARRINGTON, Pa., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

Tue, 23 Dec 2025 09:00:00 -0500

Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000

Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings

WARRINGTON, Pa., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

Tue, 23 Dec 2025 09:00:00 -0500

Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000

Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings

WARRINGTON, Pa., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on

Windtree Therapeutics signs letter of intent to acquire CommLoan

Wed, 03 Dec 2025 09:00:28 -0500

Windtree Therapeutics, Inc. (OTCID: WINT) announced it has signed a letter of intent to acquire CommLoan, Inc., a commercial real estate lending technology company. The acquisition is part of Windtree's strategy to diversify into revenue-generating businesses.

CommLoan will become a subsidiary of Windtree and retain key employees. Windtree has provided bridge financing to CommLoan during the transition period.

CommLoan operates a commercial mortgage lending marketplace through its platform called CUPID, which connects borrowers and originators with lenders nationwide. The platform allows users to compare rates, terms, and loan structures across property types including multifamily, retail, office, industrial, healthcare, and SBA financing.

"We have

Windtree Therapeutics signs letter of intent to acquire CommLoan

Wed, 03 Dec 2025 09:00:28 -0500

CommLoan will become a subsidiary of Windtree and retain key employees. Windtree has provided bridge financing to CommLoan during the transition period.

"We have

Windtree Therapeutics signs letter of intent to acquire CommLoan

Wed, 03 Dec 2025 09:00:28 -0500

CommLoan will become a subsidiary of Windtree and retain key employees. Windtree has provided bridge financing to CommLoan during the transition period.

"We have

Windtree Therapeutics signs letter of intent to acquire CommLoan

Wed, 03 Dec 2025 09:00:28 -0500

CommLoan will become a subsidiary of Windtree and retain key employees. Windtree has provided bridge financing to CommLoan during the transition period.

"We have

Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space

Wed, 03 Dec 2025 09:00:00 -0500

Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions

CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated

CommLoan has streamlined the process of obtaining commercial real estate financing

WARRINGTON, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent to acquire CommLoan, Inc., a commercial tech finance company.

Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space

Wed, 03 Dec 2025 09:00:00 -0500

Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions

CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated

CommLoan has streamlined the process of obtaining commercial real estate financing

Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space

Wed, 03 Dec 2025 09:00:00 -0500

Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions

CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated

CommLoan has streamlined the process of obtaining commercial real estate financing

Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space

Wed, 03 Dec 2025 09:00:00 -0500

Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions

CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated

CommLoan has streamlined the process of obtaining commercial real estate financing

Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space

Wed, 03 Dec 2025 09:00:00 -0500

Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions

CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated

CommLoan has streamlined the process of obtaining commercial real estate financing

Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space

Wed, 03 Dec 2025 09:00:00 -0500

Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions

CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated

CommLoan has streamlined the process of obtaining commercial real estate financing

Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space

Wed, 03 Dec 2025 09:00:00 -0500

Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions

CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated

CommLoan has streamlined the process of obtaining commercial real estate financing

Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space

Wed, 03 Dec 2025 09:00:00 -0500

Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions

CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated

CommLoan has streamlined the process of obtaining commercial real estate financing

Form 8-K WINDTREE THERAPEUTICS For: Nov 25

Tue, 02 Dec 2025 16:31:00 -0500

si-local-file:///var/storage/secattach/20251202/25689840.html

Form 8-K WINDTREE THERAPEUTICS For: Nov 25

Tue, 02 Dec 2025 16:31:00 -0500

si-local-file:///var/storage/secattach/20251202/25689840.html

Form 424B3 WINDTREE THERAPEUTICS

Fri, 21 Nov 2025 08:16:00 -0500

si-local-file:///var/storage/secattach/20251121/25647203.html